Validity and reliability of the FSS in Greek MS patients

SpringerPlus

Table 1 Demographic characteristics

Variable	Mean	SD	N
Age
MS Patients	43.17	10.19	72
Non patients	38.83	10.09	75
Gender
MS Patients			72
Male			24
Female			48
Non patients			75
Male			24
Female			51
FSS (1^st assessment)
MS Patients	4.41	1.75	72
Non patients	2.89	1.28	75
FSS (2^nd assessment)
MS Patients	4.34	1.80	72
Non patients	2.45	1.17	75
EDSS
MS Patients	2.40	1.56	72
Vitality
1^st Assessment
MS Patients	45.67	11.96	72
Control	55.13	07.58	75
2^nd Assessment
MS Patients	45.72	12.14	72
Control	56.17	09.15	75
PF
1^st Assessment
MS Patients	37.10	13.89	72
Control	52.15	07.60	75
2^nd Assessment
MS Patients	37.84	13.60	72
Control	52.15	07.60	75
BDI-II
Somatic
1^st Assessment
MS Patients	09.08	06.27	72
Control	04.96	04.29	75
2^nd Assessment
MS Patients	09.04	06.85	72
Control	04.60	04.12	75
Cognitive
1^st Assessment
MS Patients	03.88	04.16	72
Control	01.93	02.27	75
2^nd Assessment
MS Patients	03.67	04.58	72
Control	01.53	01.80	75
BDI-II Total
1^st Assessment
MS Patients	12.96	09.80	72
Control	06.89	05.94	75
2^nd Assessment
MS Patients	12.71	10.94	72
Control	06.13	05.35	75